- Home
- ECC vs SVA Comparison
ECC vs SVA Comparison
Compare ECC & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECC
- SVA
- Stock Information
- Founded
- ECC 2014
- SVA N/A
- Country
- ECC United States
- SVA
- Employees
- ECC N/A
- SVA 3261
- Industry
- ECC
- SVA
- Sector
- ECC
- SVA
- Exchange
- ECC NYSE
- SVA NYSE
- Market Cap
- ECC N/A
- SVA N/A
- IPO Year
- ECC N/A
- SVA N/A
- Fundamental
- Price
- ECC $7.99
- SVA $6.47
- Analyst Decision
- ECC Buy
- SVA
- Analyst Count
- ECC 2
- SVA 0
- Target Price
- ECC $10.50
- SVA N/A
- AVG Volume (30 Days)
- ECC 1.5M
- SVA N/A
- Earning Date
- ECC 05-20-2025
- SVA N/A
- Dividend Yield
- ECC 22.53%
- SVA N/A
- EPS Growth
- ECC N/A
- SVA N/A
- EPS
- ECC 0.76
- SVA N/A
- Revenue
- ECC $179,767,542.00
- SVA N/A
- Revenue This Year
- ECC $24.07
- SVA N/A
- Revenue Next Year
- ECC $8.43
- SVA N/A
- P/E Ratio
- ECC $10.45
- SVA N/A
- Revenue Growth
- ECC 29.26
- SVA N/A
- 52 Week Low
- ECC $6.54
- SVA N/A
- 52 Week High
- ECC $10.49
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- ECC 55.21
- SVA N/A
- Support Level
- ECC $7.82
- SVA N/A
- Resistance Level
- ECC $8.23
- SVA N/A
- Average True Range (ATR)
- ECC 0.13
- SVA 0.00
- MACD
- ECC 0.07
- SVA 0.00
- Stochastic Oscillator
- ECC 70.70
- SVA 0.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.